The differences spike proteins in cells treated with mRNA injections

https://www.mdpi.com/2076-393X/11/4/879

This article compares the levels of S proteins or spike proteins in a cell line test. They used Comirnity and Spikevax, AKA the Pfizer and the Moderna vaccines for this test. The cells were evaluated 24 hours after exposure to the 2 vaccines.

“Vaccines were obtained from three vaccination centers in Perugia (Italy) that provided us with residual vaccines present in vials after administration.” One could assume that these residual vaccine vials were “less than ideal” and were the crumbs at the bottom of the vial. Who knows how credible those vials even were at this point. They did not use a fresh properly stored vial by any means.

What did they notice? First, S-protein was detected not only on the cell membrane but also in the supernatant. Supernatant is usually the separated fluid after a specimen has been centrifuged. Think of it as the liquid that remains at the top when the solid particles sink to the bottom of a test tube. Second, the two vax brands did not perform the same. “The expression was dose-dependent only in Moderna-treated cells. Furthermore, the S-protein expression levels in both cells and supernatant were much higher in Moderna-than in Pfizer-treated cells. Differences in S-protein expression levels following vaccine treatment may be attributed to variations in the efficacy of lipid nanoparticles, differences in mRNA translation rates and/or loss of some lipid nanoparticles’ properties and mRNA integrity during transport, storage, or dilution, and may contribute to explaining the slight differences in the efficacy and safety observed between the Pfizer and Moderna vaccines.” Again, they did not use a fresh vial of vax juice here. These were the discarded crumbs. I question the credibility of the results from the waste at the bottom of a vial.

I loved this blurb: “A vaccine’s effectiveness, including COVID-19 vaccines, depends on numerous variables, including the activity of the pandemic, vaccine recipients’ demographics, lifestyles, and ethnicities.” Uhhh, since when? Do we have different versions of vaccines to account for these “differences”? No we do not. Since when did we consider the vaccine recipients ethnicity as a measure of effectiveness? We never have. That is some nonsense.

“Circulating S-protein has been shown to cause cardiovascular disease by damaging human heart pericytes through CD147 receptor binding and other unknown mechanism(s), regardless of viral infection, and myocarditis is the most common, though extremely rare, adverse event of mRNA-based vaccines. (Rare is debatable but whatever). Recent studies by Yonker et al. have shown that patients with myocarditis following COVID-19 mRNA vaccines had elevated levels of full-length S-protein, unbound by antibodies (free S-protein), in the plasma, agreeing with our findings that the S-protein is present in the supernatant of vaccine-treated cell lines. Interestingly, the full-length free S-protein was only present in vaccine recipients with myocarditis, strongly suggesting that the S-protein is responsible for vaccine-induced myocarditis.” My question here, with the Pfizer being 30ug of mRNA and the Moderna being 100ug of “spike death garbage”, how long after vaccination does it take to truly test this theory on the full length free S protein only being present in those with myocarditis? I think that is a honker of a lie. Just my opinion.

Notably, myocarditis following vaccination with mRNA-based vaccines affects young males much more frequently than other demographics. (Debatable, we have data now that many women are silently asymptomatic). In these subjects, Moderna shows a higher frequency of myocarditis than Pfizer, with increased risk ranging from 2.5 to 8 folds in different studies. (No shocker, see above the ug of mRNA in the two different arm darts). The higher mRNA dose of Moderna compared to Pfizer is believed to be the reason for the increased incidence of myocarditis. If the different in vitro S-protein expressions by Moderna and Pfizer vaccines reflect in vivo conditions, our results could contribute to explaining the disparity in myocarditis frequency. (I agree with this. 😎).